Article Sidebar

PDF
Date Published: 15/03/2024
Abstract Views: 332
Views PDF: 237
DOI: https://doi.org/10.59873/vjid.v1i45.344
Issue
Vol. 1 No. 45 (2024)
Section
Scientific research
How to Cite
Nguyen, V. G., & Nguyen, V. D. (2024). CAUSES FOR ABANDONING TREATMENT, CHARACTERISTICS OF VIRUS OUTBREAKS AND POST-TREATMENT OUTCOMES OF HEPATITIS B PATIENTS AFTER TREATMENT WITHDRAWAL AT THE NATIONAL HOSPITAL FOR TROPICAL DISEASES (2018 - 2023). Vietnam Journal of Infectious Diseases, 1(45), 20-26. https://doi.org/10.59873/vjid.v1i45.344

CAUSES FOR ABANDONING TREATMENT, CHARACTERISTICS OF VIRUS OUTBREAKS AND POST-TREATMENT OUTCOMES OF HEPATITIS B PATIENTS AFTER TREATMENT WITHDRAWAL AT THE NATIONAL HOSPITAL FOR TROPICAL DISEASES (2018 - 2023)

Van Giang Nguyen, Van Duyet Nguyen

Main Article Content

Abstract

Objectives: Describe the causes of treatment withdrawal, characteristics of viral outbreaks and posttreatment outcomes of hepatitis B patients after treatment withdrawal.
Subjects and methods: Retrospective and prospective descriptive study on 336 patients with chronic hepatitis B who took Nucleos(t)ide analogue (NA). The patient did not comply with treatment instructions and stopped NA medicine.
Results and conclusions: CAntiviral drugs used before stopping treatment: 54.2% were TDF, 14.9% were ETV, 4.5% were TAF, 26.1% were unknown. Median duration of treatment was 24 months.  Reasons for discontinuing medication are: 7.1% improved liver function, 1.2% pregnancy, 3% not being able to buy medication due to COVID-19, 21.7% not understanding the treatment course, taking medication 1.2% of traditional medicines, 64.9% of reasons cannot be exploited. Patients who stopped
taking medication for more than 12 months accounted for 32.8%.
HBV DNA viral load increased above 10^6 copies/ml in patients who stopped for <6 months accounted for 55.2%, in patients who stopped for more than 12 months accounted for 32.2%, in patients who stopped for 6 - 12 months accounted for 55.2%. 12.6%.
Treatment: The number of patients receiving plasma exchange was 11 (3.3%), treatment worsened in 3.6%.

Article Details

Keywords

Hepatitis B, treatment abandonment, antiviral

References

1. Bộ Y tế (2019). Hướng dẫn chẩn đoán và điều trị bệnh viêm gan vi rút B. Quyết định số 3310/QĐ-BYT, ký ngày 29 tháng 07 năm 2019.
2. Hirode G, Choi HSJ, Chen CH, et al. (2022). Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study). Gastroenterology. 2022;162(3):757-771.e4. doi:10.1053/j.gastro.2021.11.002.
3. AASLD. (2022). Treatment of Chronic Hepatitis B Guideline Summary. Guideline Central. Accessed July 2, 2022. https://www.guidelinecentral.com/guideline/10618.
4. Tout I, Lampertico P, Berg T, Asselah T. (2021). Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B. Antiviral Res. 2021;185:104992. doi:10.1016/j.antiviral.2020.104992.
5. Lê Thị Lan. (2021). Đặc điểm lâm sàng và các yếu tố liên quan đến suy gan cấp ở bệnh nhân xơ gan mất bù do viêm gan vi rút B tại Bệnh viện Bệnh Nhiệt đới Trung ương. Luận văn Thạc sĩ y học, Trường Đại học Y Hà Nội.
6. Van Thi Thuy Nguyen, Tran Dai, et al. (2018). "Estimates and projection of disease burden and economic analysis for hepatitis B in Viet Nam." Journal of Viral Hepatitis.
7. Dương Văn Thanh. (2014). Đánh giá hiệu quả điều trị bệnh viêm gan vi rút B thể ứ mật bằng kỹ thuật thay huyết tương tại Bệnh viện Bệnh Nhiệt đới Trung ương từ năm 2009 đến 2014. Luận văn tốt nghiệp bác sĩ chuyên khoa 2. Trường Đại học Y Hà Nội.